Detalhe da pesquisa
1.
Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes.
Drug Metab Dispos
; 51(12): 1651-1662, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37775330
2.
Activation of Pregnane X Receptor-Cytochrome P450s Axis: A Possible Reason for the Enhanced Accelerated Blood Clearance Phenomenon of PEGylated Liposomes In Vivo.
Drug Metab Dispos
; 47(8): 785-793, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118196
3.
Induction of Cytochrome P450 Involved in the Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomes In Vivo.
Drug Metab Dispos
; 47(4): 364-376, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674617
4.
PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU.
J Liposome Res
; 27(2): 161-170, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27184460
5.
Ultrastructural and glycoproteomic characterization of Prevotella intermedia: Insights into O-glycosylation and outer membrane vesicles.
Microbiologyopen
; 13(2): e1401, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38409911
6.
Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
J Pharm Sci
; 108(1): 641-651, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30595169
7.
Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
J Pharm Pharmacol
; 68(8): 980-8, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283220